Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples